Molecular epidemiology and HIV-1 variant evolution in Poland between 2015 and 2019.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
16 08 2021
Historique:
received: 19 04 2021
accepted: 05 08 2021
entrez: 17 8 2021
pubmed: 18 8 2021
medline: 16 11 2021
Statut: epublish

Résumé

The occurrence of HIV-1 subtypes differs worldwide and within Europe, with non-B variants mainly found across different exposure groups. In this study, we investigated the distribution and temporal trends in HIV-1 subtype variability across Poland between 2015 and 2019. Sequences of the pol gene fragment from 2518 individuals were used for the analysis of subtype prevalence. Subtype B was dominant (n = 2163, 85.90%). The proportion of subtype B-infected individuals decreased significantly, from 89.3% in 2015 to 80.3% in 2019. This was related to the increasing number of subtype A infections. In 355 (14.10%) sequences, non-B variants were identified. In 65 (2.58%) samples, recombinant forms (RFs) were noted. Unique recombinant forms (URFs) were found in 30 (1.19%) sequences. Three A/B recombinant clusters were identified of which two were A6/B mosaic viruses not previously described. Non-B clades were significantly more common among females (n = 81, 22.8%, p = 0.001) and heterosexually infected individuals (n = 45, 32.4%, p = 0.0031). The predominance of subtype B is evident, but the variability of HIV-1 in Poland is notable. Almost half of RFs (n = 65, 2.58%) was comprised of URFs (n = 30, 1.19%); thus those forms were common in the analyzed population. Hence, molecular surveillance of identified variants ensures recognition of HIV-1 evolution in Poland.

Identifiants

pubmed: 34400726
doi: 10.1038/s41598-021-96125-w
pii: 10.1038/s41598-021-96125-w
pmc: PMC8367969
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

16609

Informations de copyright

© 2021. The Author(s).

Références

Mol Biol Evol. 2018 Jun 1;35(6):1550-1552
pubmed: 29669107
Viruses. 2020 Jul 31;12(8):
pubmed: 32752001
Nat Med. 2009 Aug;15(8):871-2
pubmed: 19648927
Nucleic Acids Res. 2019 Jul 2;47(W1):W636-W641
pubmed: 30976793
PLoS One. 2013 Jul 23;8(7):e70126
pubmed: 23894603
Przegl Epidemiol. 2020;74(2):223-238
pubmed: 33112106
Lancet. 2012 Jul 28;380(9839):367-77
pubmed: 22819660
Infect Genet Evol. 2016 Dec;46:180-189
pubmed: 27321440
New Microbiol. 2012 Oct;35(4):377-86
pubmed: 23109005
AIDS Res Hum Retroviruses. 2008 Oct;24(10):1319-25
pubmed: 18851681
Lancet Infect Dis. 2019 Feb;19(2):143-155
pubmed: 30509777
J Virol Methods. 2008 Nov;153(2):176-81
pubmed: 18706932
BMC Med. 2019 Jan 8;17(1):4
pubmed: 30616632
J Virol. 1999 Jan;73(1):152-60
pubmed: 9847317
Mol Biol Evol. 2020 Jan 1;37(1):291-294
pubmed: 31432070
ISRN Microbiol. 2013 Jun 17;2013:481314
pubmed: 23844315
Przegl Epidemiol. ;71(3):379-390
pubmed: 29182222
Nucleic Acids Res. 2019 Jul 2;47(W1):W256-W259
pubmed: 30931475
PLoS One. 2014 Jun 12;9(6):e99390
pubmed: 24922326
PLoS Biol. 2015 Sep 16;13(9):e1002251
pubmed: 26375597
J Virol. 2019 May 29;93(12):
pubmed: 30944175
PLoS Comput Biol. 2009 Nov;5(11):e1000581
pubmed: 19956739
Nucleic Acids Res. 2014 Oct;42(18):e144
pubmed: 25120265
AIDS. 2021 Jul 15;35(9):1333-1342
pubmed: 33730748
BMC Infect Dis. 2020 Oct 7;20(1):728
pubmed: 33028235
Retrovirology. 2013 Jan 14;10:7
pubmed: 23317093
J Int AIDS Soc. 2014 Jul 04;17:18944
pubmed: 24998532
J Clin Microbiol. 2012 Jun;50(6):1936-42
pubmed: 22403431
PLoS One. 2012;7(2):e31674
pubmed: 22359615
Lancet HIV. 2018 Jun;5(6):e309-e316
pubmed: 29893244
Przegl Epidemiol. 2019;73(2):179-192
pubmed: 31385676
PLoS One. 2016 Jan 11;11(1):e0146097
pubmed: 26752062
Nucleic Acids Res. 2009 Jul;37(Web Server issue):W647-51
pubmed: 19443440
Infect Genet Evol. 2016 Apr;39:232-240
pubmed: 26851192
HIV Med. 2021 May;22(5):387-396
pubmed: 33410278
J Virol. 2010 Jun;84(12):6096-102
pubmed: 20357090
J Int AIDS Soc. 2020 Apr;23(4):e25485
pubmed: 32333726
Nucleic Acids Res. 2003 Jan 1;31(1):298-303
pubmed: 12520007
Infect Genet Evol. 2020 Jul;81:104257
pubmed: 32087346
PLoS One. 2018 Nov 8;13(11):e0206234
pubmed: 30408827
Syst Biol. 2010 May;59(3):307-21
pubmed: 20525638

Auteurs

Karol Serwin (K)

Department of Infectious, Tropical Diseases and Immune Deficiency, Pomeranian Medical University in Szczecin, Arkońska 4, 71-455, Szczecin, Poland. karol.serwin@pum.edu.pl.

Anna Urbańska (A)

Department of Infectious, Tropical Diseases and Immune Deficiency, Pomeranian Medical University in Szczecin, Arkońska 4, 71-455, Szczecin, Poland.

Kaja Scheibe (K)

Department of Infectious, Tropical Diseases and Immune Deficiency, Pomeranian Medical University in Szczecin, Arkońska 4, 71-455, Szczecin, Poland.

Magdalena Witak-Jędra (M)

Department of Infectious, Tropical Diseases and Immune Deficiency, Pomeranian Medical University in Szczecin, Arkońska 4, 71-455, Szczecin, Poland.

Maria Jankowska (M)

Pomeranian Center for Infectious Diseases and Tuberculosis, Gdańsk, Poland.

Maria Hlebowicz (M)

Pomeranian Hospital, Gdansk, Poland.
Department of Family Medicine and Infectious Diseases, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland.

Monika Bociąga-Jasik (M)

Department of Infectious and Tropical Diseases, Jagiellonian University Medical College, Kraków, Poland.

Anna Kalinowska-Nowak (A)

Department of Infectious and Tropical Diseases, Jagiellonian University Medical College, Kraków, Poland.

Martyna Biała (M)

Department of Infectious Diseases, Liver Disease and Acquired Immune Deficiencies, Wroclaw Medical University, Wrocław, Poland.

Hubert Ciepłucha (H)

Department of Infectious Diseases, Liver Disease and Acquired Immune Deficiencies, Wroclaw Medical University, Wrocław, Poland.

Władysław Łojewski (W)

Department of Infectious Diseases, Regional Hospital in Zielona Gora, Zielona Góra, Poland.

Anita Olczak (A)

Department of Infectious Diseases and Hepatology, Faculty of Medicine, Nicolaus Copernicus University Ludwik Rydygier Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland.

Elżbieta Jabłonowska (E)

Department of Infectious Diseases and Hepatology, Medical University of Łódź, Łódź, Poland.

Aldona Kowalczuk-Kot (A)

Department of Infectious Diseases, Medical University of Białystok, Białystok, Poland.

Błażej Rozpłochowski (B)

Department of Infectious Diseases, Hepatology and Acquired Immunodeficiencies, Karol Marcinkowski University of Medical Sciences, Poznań, Poland.

Adam Witor (A)

Regional Hospital, Out-Patient's Clinic for Immune Deficiency, Chorzów, Poland.

Miłosz Parczewski (M)

Department of Infectious, Tropical Diseases and Immune Deficiency, Pomeranian Medical University in Szczecin, Arkońska 4, 71-455, Szczecin, Poland.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH